Colombia restores supply of epilepsy drug Urbadan after registration change

Colombia's Ministry of Health announced that Urbadan, an epilepsy medication, is available again after a change in the holder of its sanitary registration. The supply disruption had likely affected patients relying on this treatment. The announcement signals resolution of a regulatory bottleneck, but details on distribution and stock levels remain unclear.